Reason: Conference has not started.
until file(s) become available
Minimum important difference (MID) is crucial in sample size estimation and interpretation of trial results
This is a poster presented at the 6th International Clinical Trials Methodology Conference (ICTMC 2022).
It summarises work conducted to elicit minimum important differences in DEMQOL and DEMQOL-U, two dementia specific quality of life outcome measures.
Journal article: https://doi.org/10.1007/s11136-021-02900-7
The data was from Journeying through Dementia Trial, funded by the NIHR Health Technology Assessment Programme (project number 14/140/80).
ISRCTN17993825 on 11th October 2016
EthicsThere is no personal data or any that requires ethical approval
PolicyThe data complies with the institution and funders' policies on access and sharing
Sharing and access restrictionsThe data can be shared openly
- The file formats are open or commonly used
Methodology, headings and units
- Headings and units are explained in the files